M&A Deal Summary |
|
|---|---|
| Date | 2011-05-23 |
| Target | Myconostica |
| Sector | Medical Products |
| Buyer(s) | Lab21 |
| Sellers(s) | NMT Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
Lab21 provides diagnostic products and services to blood bank screening, medical diagnostics and drug discovery partners. Lab21 is based in Cambridge, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Size | Small |
| Type | Sector Agnostic |
NMT Capital is a private equity firm focused on tech-oriented growth industries. Areas of interest include medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications, information technology, and advanced materials. NMT Capital is based in Quincy, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 10 |
| Sector: Medical Products M&A | 2 of 5 |
| Type: Add-on Acquisition M&A Deals | 2 of 9 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2011 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-01-10 |
Sabal Medical
Daniel Island, South Carolina, United States Sabal Medical, Inc. is a Charleston, SC-based developer and manufacturer of proprietary medication safety solutions. The Sabal Solution replaces traditional medication cabinets, mobile medication carts and stand-alone point of care software. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-06-09 |
Spectra Analysis Instruments
Marlborough, Massachusetts, United States Spectra Analysis Instruments is the developer and manufacturer of next-generation Molecular Analysis Instrumentation which solves the critical limitations of current Infrared technology being experienced by the life sciences and other industries, in the essential analysis of complex materials. |
Buy | - |
